A Study to Assess Safety and Efficacy of a Leishmania Vaccine to Prevent Post Kala Azar Dermal Leishmaniasis (PKDL)
Condition: Post-kala-azar Dermal Leishmaniasis Interventions: Biological: Vaccine; Other: Placebo Sponsors: University of York; Wellcome Trust Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials